Since November, 2007, the trading company of Allivictus s.r.o. has been the exclusive distributor of the Allivictus new-generation garlic tincture on the Czech market. The tincture is produced manually by the company of Ecoton. The Allivictus tincture provides the most effective way of utilization of the substances beneficial to health contained in garlic. It generally strengthens immunity and prevents civilization diseases. The Allivictus tincture is intended for children over 3, suitable and safe for pregnant and breast-feeding women as well as for diabetics.
Allivictus is produced according to the original Tibetan formula originating from the 13th century, improved and enhanced by new knowledge. Special emphasis is put on the quality and selection of the basic raw material. It is just the top-quality Czech species of garlic that is a limiting factor to large-scale production. For that reason, Allivictus cannot be bought in pharmacies (except for those pharmacies located in the clinics that cooperate in research of the Allivictus effects on diseases and disorders in the fields of gynaecology, cardiology, ORL, dermatology, neurology, internal medicine, immunology, allergology, pneumology, psychiatry and practical sports medicine). The Allicin Active ComplexTM content in Allivictus is regularly checked in randomly selected samples by the State-accredited Testing Laboratory and the results are published on the Allivictus website. Allivictus can be bought through our E-shop on the Allivictus company website or in selected pharmacies and points of sale. All the clients who have bought Allivictus via the E-shop have received their personal codes authorizing them to purchase maximum 5 sets of Allivictus a year provided that the maximum production is achieved. Our company's policy is based on our knowledge and experience in the field of medicine, pharmacy, top management as well as on duly trained and skilled sales representatives all over the Czech Republic.
Allivictus has been approved by the National Institute of Public Health in Prague by a certificate No.: 17-023/07 of 30 August 2007, it was approved also by the Ministry of Health of the Czech Republic under the No.: 21986/2007-OVZ 35.0-03. 07. 2007, as well as by the Public Health Authority of the Slovak Republic (Certificate No. OHVBPKV/9141/2007/Kr dated Oct. 23, 2007) and last but not least, Allivictus was registered in Germany under Reference Number 10 1 – 313 1 10/00307 (2008) on May 8, 2008.